Decenes Group

Information sheet

These substances were identified for action under the Chemicals Management Plan (CMP).

Summary of publications
Substance group	CAS RN	Common name (acronym)	DSL name	Draft screening assessment	Risk management scope	Proposed conclusion on section 64 criteria	Follow-up activities
Decenes Group	68649-11-6^{Table 1 Footnote a}	Hydrogenated didecene	1-Decene, dimer, hydrogenated	HTML	HTML	Meets one or more of the criteria	Refer to risk management scope
Decenes Group	68649-12-7^{Table 1 Footnote a}	Hydrogenated trimer and tetramer of decene (HTTD)	1-Decene, tetramer, mixed with 1-decene trimer, hydrogenated	HTML	HTML	Meets one or more of the criteria	Refer to risk management scope
Table 1 Footnote a This CAS RN is a UVCB (unknown or variable composition, complex reaction products, or biological materials). Table 1 Return to footnote a referrer

Timelines
Date	Activity
January 2024	Anticipated publication of the final screening assessment and proposed risk management approach.
June 24, 2023	Publication in Canada Gazette, Part I, of a notice under section 71 of CEPA 1999.
January 9, 2021	Publication and start of 60-day public comment period on the draft screening assessment and risk management scope. The related notice was published in the Canada Gazette, Part I: Vol. 155, No. 2.

In June 2023, a notice was published in the Canada Gazette, Part I: Vol. 157, No. 25 – June 24, 2023 under section 71 of the Canadian Environmental Protection Act,1999 (CEPA 1999). This notice applies to hydrogenated didecene (CAS RN 68649-11-6) and HTTD (CAS RN 68649-12-7). More information is available on the Information gathering with respect to certain substances under the Chemicals Management Plan web page.

Report a problem on this page